Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Clin Endocrinol (Oxf). 2010 Dec;73(6):752-9. doi: 10.1111/j.1365-2265.2010.03877.x.
Thyroid hormones are involved in metabolic regulation, but the degree to which they affect body weight and body mass index (BMI) in children is unclear. We examined the effect of hypo- and hyperthyroidism on weight and BMI at the time of diagnosis and after appropriate treatment.
Prospective and retrospective case series.
Children referred for thyroid dysfunction were enrolled prospectively if their total or free T4 was elevated with TSH <0·05 mIU/ml (N = 57) or if they had a subnormal total or free T4 and TSH >20 (N = 29).
Almost all patients had at least 2 classic signs or symptoms including goitre, but hyperthyroid patients had more symptoms. Mean BMI z scores at the time of diagnosis did not significantly differ between the two groups. Males with hyperthyroidism complained of weight loss more frequently and had a lower pretreatment BMI z score than hyperthyroid females. Hypothyroid patients lost a minimal amount of weight by the first follow-up (mean of 0·3 kg) and on average gained weight by the second follow-up visit. In contrast hyperthyroid patients gained a mean of 3·4 kg at the first follow-up visit and a mean of 7·1 kg by the second.
Correction of hypothyroidism resulted in minimal weight loss, suggesting that hypothyroidism does not cause significant weight gain in children. In contrast, correction of the hyperthyroid state had a somewhat greater impact on weight status. These results are consistent with prior reports but surprising given the opposite metabolic effects of hypo- and hyperthyroidism.
甲状腺激素参与代谢调节,但它们对儿童体重和体重指数(BMI)的影响程度尚不清楚。我们研究了在诊断时以及经过适当治疗后,甲状腺功能减退症和甲状腺功能亢进症对体重和 BMI 的影响。
前瞻性和回顾性病例系列。
如果他们的总 T4 或游离 T4 升高,同时 TSH<0.05mIU/ml(N=57)或总 T4 或游离 T4 降低,而 TSH>20(N=29),则将因甲状腺功能障碍而就诊的儿童前瞻性纳入研究。
几乎所有患者都至少有 2 种典型的体征或症状,包括甲状腺肿,但甲状腺功能亢进症患者的症状更多。两组患者在诊断时的平均 BMI z 评分无显著差异。患有甲状腺功能亢进症的男性比患有甲状腺功能亢进症的女性更频繁地抱怨体重减轻,且治疗前 BMI z 评分较低。甲状腺功能减退症患者在第一次随访时体重仅减轻了 0.3kg,第二次随访时平均增加了 0.3kg。相比之下,甲状腺功能亢进症患者在第一次随访时平均体重增加了 3.4kg,第二次随访时平均增加了 7.1kg。
甲状腺功能减退症的纠正导致体重略有减轻,表明甲状腺功能减退症不会导致儿童体重显著增加。相反,甲状腺功能亢进症状态的纠正对体重状况的影响更大。这些结果与之前的报告一致,但考虑到甲状腺功能减退症和甲状腺功能亢进症的代谢作用相反,结果令人惊讶。